
Silexion (SLXN) Stock Rallies In Pre-Hour Market Amid Promising Study Results
Shares of Silexion Therapeutics Corp (NASDAQ: SLXN) experienced a significant surge in premarket trading, rising 52.59% to $2.06 following the release of promising preclinical study